1. Home
  2. ACCL vs NEPH Comparison

ACCL vs NEPH Comparison

Compare ACCL & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACCL

Acco Group Holdings Limited Ordinary Shares

N/A

Current Price

$3.10

Market Cap

57.8M

ML Signal

N/A

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$5.32

Market Cap

60.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACCL
NEPH
Founded
2009
1997
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.8M
60.0M
IPO Year
2025
2004

Fundamental Metrics

Financial Performance
Metric
ACCL
NEPH
Price
$3.10
$5.32
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
82.0K
50.3K
Earning Date
02-20-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
2.91
N/A
EPS
0.08
0.14
Revenue
$4,888,824.00
$17,930,000.00
Revenue This Year
N/A
$33.32
Revenue Next Year
N/A
$12.27
P/E Ratio
$35.11
$35.00
Revenue Growth
11.91
32.36
52 Week Low
$2.10
$1.39
52 Week High
$5.00
$6.42

Technical Indicators

Market Signals
Indicator
ACCL
NEPH
Relative Strength Index (RSI) N/A 55.05
Support Level N/A $4.74
Resistance Level N/A $4.97
Average True Range (ATR) 0.00 0.31
MACD 0.00 0.01
Stochastic Oscillator 0.00 84.21

Price Performance

Historical Comparison
ACCL
NEPH

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: